Product Program year 2022 Source: CMS Open Payments

Afluria Quadrivalent

Biological Vaccines

NDC 33332-421-10

Open in the dashboard

General payments

$4,748

6 payments

Research payments

$0

0 payments

Through program year 2022, $4,748 in general payments and $0 in research payments were reported against Afluria Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $4,713 4
2021 General $35 2

Breakdown

Who paid General payments · program years 2021–2022
  1. Seqirus USA Inc $4,748 6 payments
Top recipients General payments · program year 2022
  1. Anthony Scialli Gynecology · Washington, DC $2,613 55% · 2 payments
  2. Christopher Robinson Maternal & Fetal Medicine · Mount Pleasant, SC $2,100 45% · 2 payments

Each share is of general payments naming this product in 2022.

Specialties paid General payments · program year 2022
  1. Gynecology Obstetrics & Gynecology $2,613 55% · 1 practitioner
  2. Maternal & Fetal Medicine Obstetrics & Gynecology $2,100 45% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. District of Columbia $2,613 55% · 1 recipient
  2. South Carolina $2,100 45% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

6 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record